Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute pancreatitis
|
51 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2013 | 2013 | ||||||
Androgen-Insensitivity Syndrome
|
176 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2010 | 2010 | ||||||
Atrial Fibrillation
|
584 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2018 | 2018 | ||||||
Epilepsy
|
339 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2012 | 2012 | ||||||
Metabolic Diseases
|
50 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2015 | 2015 | ||||||
Myocardial Infarction
|
680 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2016 | 2016 | ||||||
Post-Traumatic Stress Disorder
|
117 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.010 | 1 | 2019 | 2019 | ||||||
Coronary heart disease
|
1178 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 0.500 | 2 | 2018 | 2019 | |||||
Diabetic Nephropathy
|
238 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||
Hodgkin Disease
|
148 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 0.500 | 2 | 2013 | 2018 | |||||
Obesity
|
1111 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 0.500 | 2 | 2017 | 2019 | |||||
Osteoporosis
|
182 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.020 | 0.500 | 2 | 2014 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.070 | 0.714 | 7 | 2009 | 2019 | |||||
Prostate carcinoma
|
1168 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.070 | 0.714 | 7 | 2009 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 0.750 | 4 | 2007 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 0.750 | 4 | 2007 | 2018 | |||||
Ischemic stroke
|
704 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.060 | 0.833 | 6 | 2010 | 2019 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.070 | 1.000 | 7 | 2006 | 2018 | |||||
Breast Carcinoma
|
2793 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.060 | 1.000 | 6 | 2007 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.060 | 1.000 | 6 | 2007 | 2017 | |||||
Neoplasms
|
1644 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.050 | 1.000 | 5 | 2009 | 2017 | |||||
cervical cancer
|
268 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||
Cervix carcinoma
|
283 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||
Coronary Artery Disease
|
1577 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2014 | 2019 | |||||
Malignant tumor of cervix
|
245 | 0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 | 0.040 | 1.000 | 4 | 2017 | 2018 |